Randomized Open Trial Comparing 2-Dose Regimens of the Human Papillomavirus 16/18 AS04-Adjuvanted Vaccine in Girls Aged 9–14 Years Versus a 3-Dose Regimen in Women Aged 15–25 Years

Background. This randomized, open trial compared regimens including 2 doses (2D) of human papillomavirus (HPV) 16/18 AS04-adjuvanted vaccine in girls aged 9–14 years with one including 3 doses (3D) in women aged 15–25 years. Methods. Girls aged 9–14 years were randomized to receive 2D at months 0 an...

Descripción completa

Detalles Bibliográficos
Autores principales: Puthanakit, Thanyawee, Huang, Li-Min, Chiu, Cheng-Hsun, Tang, Ren-Bin, Schwarz, Tino F., Esposito, Susanna, Frenette, Louise, Giaquinto, Carlo, McNeil, Shelly, Rheault, Paul, Durando, Paolo, Horn, Michael, Klar, Maximilian, Poncelet, Sylviane, De Simoni, Stéphanie, Friel, Damien, De Muynck, Benoit, Suryakiran, Pemmaraju V., Hezareh, Marjan, Descamps, Dominique, Thomas, Florence, Struyf, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Major Articles and Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957434/
https://www.ncbi.nlm.nih.gov/pubmed/26908726
http://dx.doi.org/10.1093/infdis/jiw036

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4957434/
https://www.ncbi.nlm.nih.gov/pubmed/26908726
http://dx.doi.org/10.1093/infdis/jiw036

Ejemplares similares